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Editorial on the Research Topic
Vaccines and Immunostimulants for Finfish
The expansion of intensive fish farming in recent decades has led to increase in the number of fish
diseases (1, 2). This is partly because high stocking densities used in intensive farming cause stress
making fish more susceptible to diseases and lead to high disease transmission index due increased
contact among fish. These factors call for the need of protective vaccines (3). Understanding how
the fish immune system responds to vaccines and immunostimulants/adjuvants is crucial for the
rational development of efficient vaccines. These studies should guide the design and selection
of effective immunostimulants and vaccine antigens that are efficiently taken up, processed and
presented to cells of the adaptive immune system. Another priority of the field is the identification
of optimal correlates of protective immunity that may be used as benchmarks in the design of
long-term protective fish vaccines. This has traditionally been a challenge due to poor correlation
between protection and antibody responses (4), but new emerging tools should complement
traditional serological assays. The compilation of studies presented in this Special Issue provides
an updated look on various immunostimulants and vaccine antigens relevant to farmed fish health.
In addition, these papers also provide an update on recent discoveries in fish immunology that
could aid in the design of highly protective vaccines for finfish, as well as to establish correlates
of protection for these vaccines. Thus, we envisage that this Special Issue provides novel valuable
insights essential for all researches working on the development and implementation of immune
strategies that reduce the impact of infectious diseases in aquaculture.
IMMUNOSTIMULANTS AND INNATE IMMUNE RESPONSES
Immunostimulants (IMM) have historically been defined as substances that have the capacity to
increase innate immune responses (5). But because innate responses have been shown to greatly
influence adaptive responses, their administration along with vaccine antigens also influences the
adaptive immune responses specifically mounted to the antigen. In this case, we refer to these
immunostimulants as adjuvants. The term adjuvant is from the latin “adjuvare” meaning to help.
As an example, immunostimulants such as certain oligosaccharides, CpGs, LPS, β-glucans, or
flagellin can be administered parenterally or orally to fish without a vaccine to increase the general
immune status of the fish (6) or they can be given together with a vaccine antigen (7). To date,
commercial vaccines mostly use mineral oils as adjuvants (5). These mineral oils help induce a
more robust immune response than the antigen alone by increasing the immunogenicity of weak
antigens, prolonging the duration of antigen release at the injection site, and also stimulating and
modulating adaptive immune responses. The use of IMM as adjuvants has been exclusively assayed
experimentally, but they need to be more focused on specific immune functions that are beneficial
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for a defined antigen, without provoking a massive pro-
inflammatory response that can lead to unwanted side effects.
Thus, IMM can for example promote expression and secretion of
cytokines, soluble factors and enzymes that modulate migration
of leukocytes to antigen deposition sites, enhance antigen uptake
and the intracellular processing and presentation of antigen to
cells of the adaptive immune systems (5). Among a broad range
of IMM, chitosan oligosaccharides (COSs), synthetic pituitary
adenylate cyclase-activating polypeptide (PACAP), CpGs, and
flagellin have all been shown to stimulate the effector functions
of monocytes, macrophages, dendritic-like, and B cells in fish.
The study performed by Wu et al. showed that activation
of macrophages using three different molecular weight COSs
(∼500, ∼1,000, and 2,000∼3,000 Da) correlated with different
chitosan oligosaccharides molecular weights (COS-MWs) of
which the COS-MW with highest molecular weight had the
highest activation of macrophages. In another study, Semple
et al. showed that monocyte/macrophage- RTS11 cells pre-
treated with PACAP 24 h before infection, severely inhibited
Flavobacterium psychrophilum growth and increased expression
of pro-inflammatory cytokines together with PACAP receptors
in a dose-dependent manner. Simón et al. showed that CpGs
increased the survival of IgM+ B cells, induced their proliferation
and differentiation to plasmablasts/plasma cells, upregulated
MHC-II and co-stimulatory molecules, and increased their
phagocytic capacity while Iliev et al. showed that CpG
stimulation transformed the rainbow trout primary phagocytes
into dendritic-like-cells exhibiting long branching pseudopodia.
These dendritic-like cells expressed high pro-inflammatory genes
belonging to a Th17 response (IL-17A/F1) and a Th2 response
(IL-4/13) where IL-10 and IFNγwas downregulated. Both studies
demonstrated that CpGs are capable of modulating both the
innate and adaptive branches of the immune system in fish, thus
pointing to these molecules as optimal vaccine adjuvants. To gain
further insight on how these CpGs are recognized by the host, Lai
et al. performed an in depth study that points out that recognition
of CpGs in fish is carried out by two sensors, namely Toll-
like receptor 9 (TLR9) and TLR21, consequently demonstrating
that the signaling of CpGs is more complex in fish than in
mammals that only use TLR9 as a CpG sensor. Wangkahart
et al. showed that Yersinia ruckeri flagellin upregulated several
pro-inflammatory cytokines, acute phase proteins, antimicrobial
peptides and complement genes in multiple tissues after in vivo
administration, results that point to flagellin as another potent
immunostimulant/adjuvant for fish aquaculture.
Developing in vitro models for studying immune responses
to vaccine antigens or to IMM, is of great interest, to reduce
the use of animals and pre-evaluate the potential of these
substances through an easy method. In this sense, Wang J.
et al. developed an in vitro model for studying responses to
immunostimulation in the gut using rainbow trout intestinal
epithelial cells (RTgutGC) propagated on conventional culture
plates and transwell membranes, which they used to evaluate
gut responses to stimulation by LPS and three functional feed
ingredients namely; (i) mannanoligosaccharides (MOS), (ii)
β-glucans, and (iii) nucleotides. MOS was found to be the most
potent immunostimulant that upregulated several inflammatory
cytokines such IL-1β, IL-6, IL-8, TNFα, and TGFβ at similar
levels with LPS while nucleotides and β-glucans only upregulated
IL-1β and IL-8. Overall, RTgutGC cells had features characteristic
of functional intestinal cells and therefore offer a useful in
vitro model useful for evaluating the effects of IMM and feed
ingredients on gut immune responses.
TRAINED IMMUNITY
Recent advances in innate immune studies show that both
myeloid cells such as monocytes, macrophages and dendritic cells
display changes in their metabolic and epigenetic programming
to become hyperresponsive to second stimulation by the same
antigen (8). This de facto “innate immune memory” is commonly
referred to as “trained immunity” (8). The review by Zhang et al.
discusses the role of IMMs such as β-glucans and TLR ligands in
trained innate immunity in fish. Additionally, they describe how
trained immunity can be introduced in brood stock fish and their
offspring, highlighting its potential application as an alternative
method to conventional vaccination.
ANTIGEN SAMPLING CELLS
Antigen uptake through mucosal surfaces by specific antigen
sampling cells (ASCs) is well-documented in mammals where
it is mainly done by M-cells (9). However, specific ASCs have
not been described in fish despite the identification of several
mucosal tissues that include the gills, skin, the digestive tract
and the nose. To gain further insight on antigen uptake at
mucosal surfaces, a key process for the optimization of mucosal
vaccines, Kato et al. identified two phenotypes of ASCs able to
take up antigens through rainbow trout gills. One phenotype
had large vacuoles in the cytoplasm and expressed CD45,
MHC-II, CD83, IL-1β, and IL-12p40b. Morphologically, this
subset features of monocyte, macrophage and dendritic cells.
The second phenotype exhibited features similar to mammalian
M-cells that bind lectin UEA-1 but not WGA and expressed
the surface marker Anxa5. Unlike mammalian M-cells, teleost
M-like-cells possessed small vacuoles in the cytoplasm, but
played a role in antigen sampling using mechanisms similar to
the bona-fide M-cells and expressed genes linked to phagosome,
lysosome, and antigen processing and presentation pathways
seen in mammalian M-cells.
IDENTIFICATION OF PROTECTIVE
ANTIGENS FOR VACCINE DESIGN
Pathogen diversity poses a challenge for the selection of vaccine
candidates with broad protective ability across variant strains.
To this aim, various techniques aimed at identifying vaccine
antigen candidates with broad protective abilities are being
sought. For example, Wang Y. et al. used the isobaric tag
for relative and absolute quantification (iTRAQ), to identify
protective biomarkers among 341 Aeromonas hydrophila genes
expressed in response to iron starvation. By knocking out three
genes that had low protease activity, they constructed three
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avirulent mutants as live vaccines that produced high protection
in zebrafish (Danio rerio). Another approach used to identify
broadly protective antigens is by performing multiple sequence
alignments to identify conserved antigenic proteins protective
across variant strains. Wang E. et al. used this approach to design
a Yersinia ruckeri outer membrane porin F (OmpF) vaccine after
identifying a highly conserved motif among 15 sequences of
Yersinia species, which confered increased protection and high
antibody responses in channel catfish. Similarly, the paper by
Maiti et al. provides a detailed account of various in silico and
bioinformatics analytical tools used to identify outer membrane
protein (OMP) antigens with broad protective abilities against
variant strains of different bacterial species infecting major
farmed fish species in India.
LIVE ATTENUATED AND RECOMBINANT
VACCINES
Although there are many commercial antibacterial vaccines
available for use in aquaculture, there are still some bacterial
pathogens for which vaccines have not been developed or are
deficient. In this Special Issue, different recombinant approaches
have been explored. Abdelhamed et al. produced a recombinant
A. hydrophila ATPase protein vaccine that showed increased
survival and reduced bacterial concentrations in different tissues
of catfish after challenge with virulent A. hydrophila ML09-119
strain. Lange et al. showed a progressive increase of systemic and
mucosal IgM levels over a period of 2 years in catfish immunized
by bath using a recombinant DnaK (rDnaK) vaccine made from
the Flavobacterium columnare DnaK heat-shock-protein (Hsp70
protein). Finally, Maiti et al. reviewed the use of outer membrane
proteins (OMPs) as subunit, DNA and nanoparticle vaccines
against different pathogens infecting farmed fish in India. In
the case of intracellular replicating bacteria, an efficient vaccine
should be able to evoke both humoral and cell-mediated immune
responses able to eliminate infected cells. To this end, Kordon
et al. developed two live attenuated vaccines (LAVs) designated
as Ei1evpB, and ESC-NDKL1 against Edwardsiella ictaluri,
a facultative intracellular replicating bacterium. Both LAVs
elevated IFN-γ expression in lymphoid organs that correlated




Temperature manipulation is an important factor known to alter
virulence of various fish pathogens (10) as well as the immune
responses of the fish host (11). Although several studies have
shown that virulence factors can be controlled by thermo-sensors
in different bacterial pathogens (10, 12), little is known regarding
how modulating temperature changes influence the ability of
the host responses to mount protective immune responses
against invading pathogens. The study undertaken by Jiang et al.
showed that crucian carp (Carassius carassiuss) cultured at 30◦C
showed an increased tricarboxylic acid (TCA) cycle linked to
reduced taurine and hypotaurine metabolism coupled with low
unsaturated fatty acid biosynthesis, which enhanced bacterial
infection in a dose-dependent manner in fish. Conversely,
exogenous treatment of fish using thesemetabolites increased fish
survival and rescued the decline of pro-inflammatory cytokine
expression that included TNF-α1, TNF-α2, IL-1β1, IL-1β2, and
lyz expression. This study shows that changes in the interplay
between temperature and fish metabolism can be used to regulate
immune protection against bacterial infection in fish.
B CELL IMMUNE RESPONSES IN
VACCINATED FISH
Antibody production together with cell mediated immune
responses constitute the hallmark of long-term protective
immunity in vaccinated fish. As such, antibodies produced by
B cells, are widely used as a measure of immune response to
vaccination in fish (4). Along this line, Teige et al. developed a
multiplexed bead antibody assay able to differentiate antibody
responses induced by piscine reovirus (PRV) σ1, σ2, and σ3
antigens. In trying to elucidate factors driving the specificity of
fish antibodies, Magadan et al. searched for “public” antibody
clonotypes common to all individuals that may mediate universal
protection against pathogens. Through CD3 spectratyping of
splenic B cells 5 months after vaccination with an attenuated viral
haemorrhagic septicaemia virus (VHSV) vaccine, they showed
that the IgM repertoires of vaccinated fish had altered profiles
for the heavy chain variables (VH) VH1, VH4, and VH5 families.
The altered profile of VH5 was the only clonotype found in all
vaccinated individuals, suggesting that it may contain a persisting
public component, while responses associated with VH1 and
VH4 varied from fish to fish. Further analysis of the variable
(V), joining (J), and diversity (D) gene segments showed that the
VH5 and JH5 clonotypes formed persistent public VH5JH5 IgM
dominant antibodies common to all vaccinated individuals. In
addition to these studies, Peñaranda et al. obtained a cell surface
proteome of Atlantic salmon IgM+ B cells by mass spectrometry
and comparing it to that of two adherent salmon head kidney
cell lines and used it to identify specific markers of B cells,
namely CD22 and CD79A, in salmon. The identification of these
molecules is very important to track B cell responses to vaccines
and/or immunostimulants in the future.
MEASURES OF PROTECTIVE IMMUNITY
FOR FISH VACCINES
To a large extent, the correlates of protective immunity for
most fish vaccines are unknown. Moreover, whether common
signatures of protective immunity across different fish species
can be identified or not remains a challenge. However, novel
high throughput sequencing (HTS) techniques such as RNA-seq
that provide whole transcriptomes of immune genes expressed in
response to different stimuli are beginning to unravel different
molecular markers that could serve as signatures of protective
immunity expressed by different fish species in response to
different pathogens. The study performed by Maekawa et al.
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describes the use of RNA-seq as a useful tool used to identify the
universality and diversity of immune responses against different
pathogens expressed in different fish species by comparing
immune genes expressed in response to Nocardia seriolae in
largemouth bass (Micropterus salmoides), Lactococcus garvieae
in gray mullet (Mugil cephalus), Vibrio harveyi in orange-
spotted grouper (Epinephelus coioides), and Aeromonas sobria
in koi carp (Cyprinus carpio). They found 39 differentially
expressed immune genes that were present in all fish species
having the potential to serve as universal immunological markers
of protective immunity. This study suggests that common
signatures of protective immunity can be identified for use across
different fish species.
Overall, the ccontributions gathered in this Special Issue
provide a wide range of novel approaches and technologies being
developed aimed at producing highly protective vaccines for
finfish. What is now required is translation of these experimental
findings to the fish farming industry with the objective of
reducing the disease burden in aquaculture through vaccination.
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